Table 4.
Biomedical indicators at study end
| Patients who have a single condition occurring alone | The condition occurs with other conditions, causing multimorbidity | Both combined | |
| Blood pressure (mm Hg), number (%) | n=415 | n=469 | n=884 |
| ≥140/90 | 183 (44.1) | 225 (48.0) | 408 (46.2) |
| <140/90 | 232 (55.9) | 244 (51.2) | 476 (53.9) |
| ≥180/120 | 7 (1.7) | 25 (5.3) | 32 (3.6) |
| <180/120 | 408 (98.3) | 444 (94.7) | 852 (96.4) |
| Systolic BP mm Hg, mean (range) | 133.9 (26.0–228) | 136.7 (90.0–227) | 135.4 (26–228) |
| Diastolic BP mm Hg, mean (range) | 83.9 (53–130) | 85.6 (44–185) | 84.8 (44–185) |
| Fasting glucose (mmol/L), number (%) | n=189 | n=242 | n=431 |
| <6.1 | 36 (19.1) | 69 (28.5) | 105 (24.4) |
| 6.1–6.9 | 28 (14.8) | 33 (13.6) | 61 (14.2) |
| ≥7.0 | 125 (66.1) | 140 (57.9) | 265 (61.5) |
| Fasting glucose, mean (range) mmol/L | 9.7 (3.6–28.5) | 8.3 (3.6–19.8) | 8.9 (3.6–28.5) |
| HbA1c, number (%). | n=84 | n=140 | n=224 |
| <6% | 17 (20.2) | 31 (22.1) | 48 (21.4) |
| 6.0%–6.4% | 4 (4.8) | 15 (10.7) | 19 (8.5) |
| ≥6.5% | 63 (75.0) | 94 (67.1) | 157 (70.1) |
| HbA1c, mean (range) percent | 7.6 (0.6–13.5) | 7.3 (0.6–15.9) | 7.4 (0.6–15.9) |
| HIV plasma viral load, number (%)* | n=322 | n=156 | n=478 |
| <100 copies/mL | 278 (86.3) | 145 (93.0) | 423 (88.5) |
| 100–999 copies/mL | 27 (8.4) | 9 (5.8) | 36 (7.5) |
| ≥1000 copies/mL | 17 (5.3) | 2 (1.3) | 19 (4.0) |
Note: 80 persons were newly diagnosed with second or third conditions over the course of the follow-up (see table 3). Their final follow-up indicators are not included in the analyses above as these patients may have been newly started on treatment and therefore will not have had time to stabilise.
*The 95% CI for plasma viral load <100 copies/mL for both groups combined was 85.7, 91.4%. The proportion with plasma viral load <1000 copies/mL was 96.0% (95% CI: 94.3% to 97.8%).
BP, blood pressure; HbA1c, glycated haemoglobin.